Christopher is also a Sanofi board member and a member of the Strategy Committee. Since April 2011, he has also been the Chairman of Genzyme. In 2011, net sales reached €33,389 million ...

Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...

I am excited to work alongside the other Board members and the leadership team to continue advancing ... Prior to his time at Intercept, Mr. Durso spent over two decades at Sanofi, where he held ...

Among racial and ethnic groups, non-Hispanic white adults reported the highest rate of seasonal allergies (28.4%), followed ...

The FSHD Society, a leading nonprofit dedicated to advancing research and improving the lives of individuals with facioscapulohumeral muscular dystrophy (FSHD), proudly announces the appointment of ...

Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...

WISE Trust, the leading pension administrator of retirement solutions for Workplace Safety and Insurance Board Employees in Ontario, is pleased to announce a robust net return of 11.3% for the fiscal ...

Commercial Launch Preparations Advancing Prior to September 26 PDUFA Date; Regulatory Filings Under Review in U.S., Europe and ChinaTopline ...

Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other ...

Stocks to watch, LIC, Transrail Lighting, Coal India, GE Power, Schaeffler India, KSB, Paisabazaar, Chemplast Sanmar, Sanofi, ...